Plerixafor recalls

The FDA has published 2 recalls involving Plerixafor since 2016. The latest was reported on 17 May 2017. Sanofi-Aventis U.S has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 May 2017

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why plerixafor is recalled

Other Reasons150%
Packaging Defects150%

Companies

By year

2017150%
2016150%

All plerixafor recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
17 May 2017Drug	CLASS III	Mozobil (plerixafor injection) 24mg/ (20mg/mL), For Single Use Only recalledMozobil	Sanofi-Aventis U.S	Packaging Defects	NJ
28 Sep 2016Drug	CLASS III	Mozobil (plerixafor injection) 24 mg/ (20 mg/mL) per vial recalledMozobil	Genzyme Corporation / Genzyme Biosurgery	Other	Nationwide

Should you stop taking Plerixafor?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.